IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Cosentini, Deborah
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.780
EU - Europa 998
AS - Asia 316
AF - Africa 3
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.770
PL - Polonia 313
IT - Italia 188
CN - Cina 132
FI - Finlandia 112
HK - Hong Kong 109
DE - Germania 99
UA - Ucraina 86
IE - Irlanda 76
GB - Regno Unito 36
SE - Svezia 29
VN - Vietnam 28
BE - Belgio 23
FR - Francia 21
IN - India 19
JP - Giappone 15
CA - Canada 10
NL - Olanda 6
RU - Federazione Russa 5
SG - Singapore 5
AZ - Azerbaigian 2
CL - Cile 2
TH - Thailandia 2
TW - Taiwan 2
ZW - Zimbabwe 2
AL - Albania 1
AU - Australia 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.103
Salva come PNG Salva come JPEG
Città #
Warsaw 313
Fairfield 275
Ashburn 190
Chandler 157
Seattle 119
Woodbridge 111
Hong Kong 108
Helsinki 107
Houston 105
New York 96
Wilmington 79
Cambridge 78
Jacksonville 76
Princeton 69
Ann Arbor 43
Dublin 42
Beijing 40
Brescia 35
West Jordan 32
Dong Ket 28
Shanghai 25
Brussels 23
Menlo Park 22
Dearborn 20
Milan 20
Los Angeles 17
Nanjing 16
Naples 16
San Diego 13
Pune 12
Rome 11
Washington 11
Des Moines 10
Gumyojicho 9
London 9
Nanchang 8
Turin 7
Changsha 6
Fukuoka 6
Jinan 6
Chicago 5
Lappeenranta 5
Perugia 5
San Francisco 5
Shenyang 5
Tianjin 5
Dalmine 4
Hebei 4
Livorno 4
Phoenix 4
Redwood City 4
Barberino di Mugello 3
Genoa 3
Guangzhou 3
North York 3
Norwalk 3
Rockville 3
Toronto 3
Augusta 2
Bergamo 2
Berlin 2
Borås 2
Brooklyn 2
Chiswick 2
Falkenstein 2
Fuzhou 2
Gradara 2
Gunzenhausen 2
Hounslow 2
Huizen 2
Leawood 2
Leipzig 2
Melfi 2
New Bedfont 2
Ottawa 2
Pianello del Lario 2
Poli 2
Quarrata 2
Rochester 2
San Felice A Cancello 2
Taichung 2
Taizhou 2
Würzburg 2
Zhengzhou 2
Acton 1
Amsterdam 1
Arcore 1
Ardabil 1
Baku 1
Bengaluru 1
Bratislava 1
Cabrils 1
Cairate 1
Calcinato 1
Campogalliano 1
Caserta 1
Cinisello Balsamo 1
Dallas 1
Delhi 1
Dietikon 1
Totale 2.509
Salva come PNG Salva come JPEG
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 175
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 167
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 159
Immunotherapy failure in adrenocortical cancer: where next? 153
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 143
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 142
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 140
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 121
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 114
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 110
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 103
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 96
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 95
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 92
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 86
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 85
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 77
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 72
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 59
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 58
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 46
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 46
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 44
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 43
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 41
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 40
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 38
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 37
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 36
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 35
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 32
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 32
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 30
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 27
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 27
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 26
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 26
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 25
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 23
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 21
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 21
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 20
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 19
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 19
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 17
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 17
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 16
null 14
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 13
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 12
null 11
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 11
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 11
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 11
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 11
null 8
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 8
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 7
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 5
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 5
Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review 4
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial 3
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors (Journal of Endocrinological Investigation, (2023), 10.1007/s40618-023-02174-5) 2
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 2
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 2
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 1
Totale 3.192
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201982 0 0 0 0 0 0 0 0 0 0 39 43
2019/2020679 47 18 21 63 53 82 75 79 66 70 47 58
2020/2021768 35 88 72 91 67 74 32 68 48 88 38 67
2021/2022398 37 10 12 76 19 27 15 20 17 55 31 79
2022/2023440 50 22 27 31 36 96 4 48 56 16 29 25
2023/2024756 43 32 75 75 74 171 27 50 135 63 11 0
Totale 3.192